0% found this document useful (0 votes)
20 views1 page

Digitoxin: Properties and Assay Method

The document provides detailed specifications and testing methods for Digitoxin, a potent cardiotonic glycoside derived from Digitalis species. It includes information on assay preparation, chromatographic conditions, and identification tests to ensure the quality and potency of the substance. Digitoxin must be handled with care due to its high potency, and the document outlines strict guidelines for its packaging and storage.
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
20 views1 page

Digitoxin: Properties and Assay Method

The document provides detailed specifications and testing methods for Digitoxin, a potent cardiotonic glycoside derived from Digitalis species. It includes information on assay preparation, chromatographic conditions, and identification tests to ensure the quality and potency of the substance. Digitoxin must be handled with care due to its high potency, and the document outlines strict guidelines for its packaging and storage.
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Printed on: Fri Jan 05 2024, 09:19:59 PM(EST) Status: Currently Official on 06-Jan-2024 DocId: GUID-8EE779EC-BD0C-4B1C-85D1-374C32E30B26_3_en-US

Printed by: USP NF Official Date: Official as of 01-May-2020 Document Type: USP @2024 USPC
Do Not Distribute DOI Ref: uil13 DOI: [Link]
1

long-wavelength UV light: the RF value of the principal spot


Digitoxin obtained from the test solution corresponds to that obtained
from the Standard solution.
C: The retention time of the major peak in the
chromatogram of the Assay preparation corresponds to that of
the major peak in the chromatogram of the Standard
preparation, as obtained in the Assay.
Loss on drying á731ñ—Dry it in vacuum at 105° for 1 hour: it
loses not more than 1.5% of its weight.
Residue on ignition á281ñ: negligible, from 100 mg.
Assay—
C41H64O13 764.94 Mobile phase—Prepare a filtered and degassed mixture of
Card-20(22)-enolide, 3-[(O-2,6-dideoxy-β-D-ribo- water and acetonitrile (55:45). Make adjustments if necessary
hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo- (see System Suitability under Chromatography á621ñ).
hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl) Standard preparation—Dissolve an accurately weighed
oxy]-14-hydroxy, (3β,5β)-. quantity of USP Digitoxin RS in Mobile phase, and dilute
Digitoxin CAS RN®: 71-63-6; UNII: E90NZP2L9U. quantitatively, and stepwise if necessary, with Mobile phase to
obtain a solution having a known concentration of about 40
» Digitoxin is a cardiotonic glycoside obtained µg per mL.
from Digitalis purpurea L., Digitalis lanata Ehrh. Assay preparation—Transfer about 50 mg of Digitoxin,
accurately weighed, to a 200-mL volumetric flask. Dissolve in
(Fam. Scrophulariaceae), and other suitable and dilute with Mobile phase to volume, and mix. Pipet 4 mL

al
species of Digitalis. Digitoxin contains not less than of this solution into a 25-mL volumetric flask, dilute with
92.0 percent and not more than 103.0 percent Mobile phase to volume, and mix.
of C41H64O13, calculated on the dried basis. System suitability preparation—Prepare a solution in
[CAUTION—Handle Digitoxin with exceptional care Mobile phase containing about 40 µg each of digitoxin and
since it is highly potent.]
ci digoxin per mL.
Chromatographic system (see Chromatography á621ñ)—
Packaging and storage—Preserve in tight containers. The liquid chromatograph is equipped with a 218-nm
USP Reference standards á11ñ— detector and a 3.9-mm × 30-cm column that contains packing
USP Digitoxin RS L1. The flow rate is about 1 mL per minute. Chromatograph
the Standard preparation and the System suitability preparation,
Identification—
ffi
and record the peak responses as directed for Procedure:the
relative retention times are about 0.35 for digoxin and 1.0 for
Change to read: digitoxin; the resolution, R, between the digoxin and digitoxin
A: ▲Spectroscopic Identification Tests á197ñ, Infrared peaks is not less than 2.0; the tailing factor for the analyte peak
Spectroscopy: 197K▲ (CN 1-May-2020). is not more than 2.0; and the relative standard deviation for
B: Prepare a test solution in methanol containing 1 mg per replicate injections of the Standard preparation is not more
O

mL. Apply 1 µL of the test solution and 1 µL of a Standard than 2.0%.


solution of USP Digitoxin RS in methanol containing 1 mg per Procedure—Separately inject equal volumes (about 50 µL)
mL to a suitable thin-layer chromatographic plate (see of the Standard preparation and the Assay preparation into the
Chromatography á621ñ) coated with a 0.25-mm layer of chromatograph, record the chromatograms, and measure the
chromatographic silica gel mixture. Allow the applications to responses for the major peaks. Calculate the quantity, in mg,
dry, and develop the chromatogram in a solvent system of C41H64O13 in the portion of Digitoxin taken by the formula:
consisting of a mixture of methylene chloride and methanol
(93:7) until the solvent front has moved about three-fourths 1.25C(rU/rS)
of the length of the plate. Remove the plate from the
developing chamber, mark the solvent front, and dry the plate in which C is the concentration, in µg per mL, of USP Digitoxin
at 100° to remove the solvent. Spray the plate with a 6 in 10 RS in the Standard preparation, and rU and rS are the peak
solution of sulfuric acid in methanol, heat at 105° for 10 responses obtained from the Assay preparation and the
minutes, and examine the chromatogram under Standard preparation, respectively.

[Link] 1/1

Common questions

Powered by AI

The assay for Digitoxin involves preparing both a Standard preparation and an Assay preparation, each dissolved in a mobile phase of water and acetonitrile. Specific amounts are measured to obtain a solution of known concentration. The liquid chromatograph is used to inject equal volumes of these preparations, and peak responses are recorded. The quantity of C41H64O13 in Digitoxin is calculated using the formula 1.25C(rU/rS), where C is the concentration of the standard, and rU and rS are the peak responses from the assay and standard preparations, respectively. System suitability parameters must also be met, ensuring accurate results .

The identification of Digitoxin is achieved using thin-layer chromatography and liquid chromatography with a 218-nm detector. For thin-layer chromatography, a test solution and a standard solution of USP Digitoxin RS are applied to a silica gel-coated plate and developed in a methylene chloride and methanol solvent system. The plate is analyzed under UV light after being treated with sulfuric acid in methanol. For liquid chromatography, the system uses a 3.9-mm × 30-cm column with packing L1, operated at about 1 mL per minute. The peak responses for digoxin and digitoxin are recorded with relative retention times around 0.35 and 1.0, respectively .

Infrared spectroscopy plays a critical role in identifying functional groups and verifying the chemical structure of Digitoxin, serving as a spectroscopic identification test. This method ensures the presence of specific molecular bonds like hydroxyl groups is consistent with the digitoxin structure, contributing to confident identification before further chromatographic analysis. It ensures structural integrity and assists in distinguishing Digitoxin from similar compounds .

System suitability tests for the chromatography of Digitoxin include ensuring the resolution between digoxin and digitoxin peaks is not less than 2.0, the tailing factor for the analyte peak is not more than 2.0, and the relative standard deviation for replicate injections of the Standard preparation does not exceed 2.0%. These criteria ensure the chromatographic system is performing correctly, guaranteeing precise and accurate quantification of Digitoxin .

Retention time alignment is confirmed by comparing the major peak in the chromatogram from the Assay preparation with the major peak in the chromatogram from the Standard preparation. Both should correspond closely, indicating that the sample and standard are behaviorally alike in the chromatographic system, an essential step to validate the assay's accuracy and consistency .

For the quantification of Digitoxin, the relative retention time for the assays is 1.0. A margin of error for retention times is implied through system suitability requirements, ensuring reproducibility and accuracy. The significance lies in maintaining consistent separation and peak identification, reducing the likelihood of co-elution with other compounds, and ensuring the system's reliability per regulatory standards .

Digitoxin must be handled with exceptional care because it is highly potent. This precaution is crucial to prevent possible overdose or poisoning, as the compound is a potent cardiotonic glycoside. The requirement to preserve it in tight containers further underscores its potency and sensitivity to external conditions, ensuring its stability and safety during storage .

The chromatogram for Digitoxin identification is developed using a thin-layer chromatographic plate, with methylene chloride and methanol as the solvent system. After the solvent front moves three-fourths of the plate's length, it is dried and sprayed with a sulfuric acid in methanol solution, followed by heating. Correct identification is confirmed when the RF value of the principal spot for the test solution matches that of the Standard solution under long-wavelength UV light, indicating identical chemical behavior .

The moisture content of Digitoxin is assessed by drying it in a vacuum at 105°C for 1 hour. The loss on drying should not exceed 1.5% of its weight, indicating the acceptable level of moisture content to ensure the compound's stability and efficacy .

The chemical purity of Digitoxin is critical due to its therapeutic use and potency. It must contain not less than 92.0% and not more than 103.0% of C41H64O13, calculated on a dried basis. This range ensures that the active ingredient's potency is within therapeutic limits, avoiding under-treatment or toxicity. Exacting purity standards are imperative for the efficacy and safety of medical treatments developed using this compound .

You might also like